COMMUNIQUÉS West-GlobeNewswire

CVRx Appoints John Landry as Chief Financial Officer
21/09/2026
Landry Brings Two Decades of Medtech and Public Company Finance Experience MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on [...]
Let’s Beat Breast Cancer Give-A-Thon Brings Celebrities, Breast Cancer Experts, and Survivors Together to Share Prevention Information and Inspire Action
21/09/2026
Virtual event airs live on Tuesday, Sept. 22, 2026, at 8 p.m. ET on YouTube WASHINGTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Breast cancer experts, celebrities, advocates, and survivors will come together Tuesday evening [...]
Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update
21/09/2026
Jemperli global net sales of $644 million (£480 million) for the six months ended June 30, 2026, representing 34% year-over-year growth Positive interim results from the pivotal AZUR-1 trial of Jemperli in untreated [...]
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
21/09/2026
PONTE VEDRA, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan [...]
TOMI Environmental Solutions Announces Mutual Termination of Merger Agreement with Carbonium Core
21/09/2026
FREDERICK, Md., Sept. 21, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, and Carbonium Core, Inc. (“Carbonium”), [...]
Onco360® is a participating specialty pharmacy in the ZENBEXUS™ (iberdomide) limited dispense network
21/09/2026
LOUISVILLE, Ky., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a participating pharmacy by Bristol-Myers Squibb for ZENBEXUS™ (iberdomide), [...]
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
21/09/2026
CEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus [...]
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
21/09/2026
By continuously delivering medicine into the eye through the Contivue refillable implant, Susvimo is the first and only continuous delivery treatment that offers an alternative to standard-of-care eye injections for [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2026
21/09/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Comprehensive Healthcare funds additional faculty position to grow Central Washington University’s graduate counseling program
21/09/2026
Ongoing collaboration addresses growing need for behavioral health professionals regionally YAKIMA, Wash., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is proud to announce more than $300,000 in funding [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
21/09/2026
Déclaration de transactions sur actions propres Paris, France (21 septembre 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 28 avril 2026, EssilorLuxottica déclare que le 18 septembre [...]
EssilorLuxottica: Disclosure of transactions in own shares
21/09/2026
Disclosure of transactions in own shares Paris, France (September 21, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that [...]
Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
21/09/2026
CAMBRIDGE, Mass., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T [...]
Signature d’une nouvelle ligne de crédit renouvelable syndiquée de 700 millions d’euros à échéance 2031
21/09/2026
Communiqué de presse 21 septembre 2026 Signature d’une nouvelle ligne de crédit renouvelable de 700 millions d’euros à échéance 2031 Paris, le 21 septembre 2026 : à la suite du succès de son offre de 500 millions d’ [...]
Signing of a new €700 million syndicated revolving credit facility maturing 2031
21/09/2026
Press Release 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026 : following the success of its €500 million senior bonds offering completed on 8 [...]
Provider Direct Initiative Improves Access to Care at Children’s National
21/09/2026
Washington, DC, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Children’s National has launched Provider Direct, a new initiative to enhance and streamline families’ access to specialty care across the Mid-Atlantic region. Provider [...]
FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing
21/09/2026
New rule supports wider use of innovative testing methods while maintaining existing safety standards for human drug development Silver Spring, MD, Sept. 21, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
Regulated information: Fagron increases share capital through exercise subscription rights
21/09/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 21 March 2026 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of [...]
Alzinova Advances Dual Approach to Alzheimer’s Treatment and Diagnosis as World Alzheimer’s Day Highlights Unmet Need
21/09/2026
GOTHENBURG, Sweden, Sept. 21, 2026 (GLOBE NEWSWIRE) -- As World Alzheimer’s Day highlights the continued unmet need in Alzheimer’s disease, Swedish clinical-stage biopharmaceutical company Alzinova AB (Nasdaq First [...]

Pages